Victrex plc (LON:VCT - Get Free Report) shares hit a new 52-week low during trading on Thursday . The stock traded as low as GBX 933 ($12.32) and last traded at GBX 962 ($12.71), with a volume of 161420 shares. The stock had previously closed at GBX 953 ($12.59).
Wall Street Analyst Weigh In
Separately, Berenberg Bank dropped their price target on Victrex from GBX 1,491 ($19.70) to GBX 1,290 ($17.04) and set a "hold" rating on the stock in a research report on Wednesday, August 28th.
View Our Latest Report on Victrex
Victrex Trading Up 0.9 %
The company has a quick ratio of 1.99, a current ratio of 5.30 and a debt-to-equity ratio of 16.99. The firm's 50 day moving average is GBX 1,034.46 and its two-hundred day moving average is GBX 1,178.12. The stock has a market cap of £837.23 million, a price-to-earnings ratio of 2,788.57, a price-to-earnings-growth ratio of 1.92 and a beta of 0.69.
Insider Activity
In other Victrex news, insider Jakob Sigurdsson bought 3,000 shares of the business's stock in a transaction on Friday, July 5th. The shares were purchased at an average price of GBX 1,189 ($15.71) per share, with a total value of £35,670 ($47,120.21). In other news, insider Jakob Sigurdsson acquired 3,000 shares of the business's stock in a transaction dated Friday, July 5th. The stock was acquired at an average price of GBX 1,189 ($15.71) per share, for a total transaction of £35,670 ($47,120.21). Also, insider Ros Rivaz bought 1,950 shares of the stock in a transaction that occurred on Monday, August 5th. The shares were purchased at an average cost of GBX 1,020 ($13.47) per share, for a total transaction of £19,890 ($26,274.77). Over the last ninety days, insiders purchased 18,053 shares of company stock valued at $19,439,953. 1.65% of the stock is currently owned by insiders.
About Victrex
(
Get Free Report)
Victrex plc, through its subsidiaries, engages in the manufacture and sale of polymer solutions worldwide. The company operates through two segments, Sustainable Solutions and Medical. It develops PEEK and PAEK based polymer solutions, and semi-finished and finished parts. The company also provides specialist solutions for medical device manufacturers; sells thermoplastic polymers; sustainable solutions for energy and industrial, VAR, automotive, aerospace, and electronics markets; and engages in trading activities.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Victrex, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Victrex wasn't on the list.
While Victrex currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
